Skip to main content

Table 3 Short- and long-term odds ratios considering adiponectin.

From: Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study

  Adiponectin quartiles Short-term follow-up
  I - III IV Crude Adjusted*
  n = 627 n = 209 OR 95% CI OR 95% CI
Death 10 (1.6) 2 (1.0) 0.6 0.4-5.7 0.4 0.1-2.0
MI/PCI 15 (2.4) 5 (2.4) 1.0 0.4-2.8 1.0 0.3-2.7
Stroke 20 (3.2) 11 (5.3) 1.7 0.8-3.6 1.5 0.7-3.3
Renal failure 33 (5.3) 22 (10.5) 2.1 1.2-3.7 1.4 0.7-2.7
Re-exploration 54 (8.6) 22 (10.5) 1.2 0.7-2.1 0.9 0.6-1.9
Infections 29 (4.6) 11 (5.3) 1.1 0.6-2.3 1.0 0.5-2.1
CVD composite 43 (6.9) 17 (8.1) 1.2 0.7-2.2 1.0 0.6-1.9
  Adiponectin quartiles Long-term follow-up
  I - III IV Crude Adjusted
  n = 617 n = 207 OR 95% CI OR 95% CI
Death 13 (2.1) 17 (8.2) 4.2 2.0-8.7 2.9 1.3-6.4
MI/PCI 18 (2.9) 4 (1.9) 0.7 0.2-2.0 0.7 0.2-2.1
Stroke 8 (1.3) 5 (2.4) 1.9 0.6-5.8 1.4 0.4-4.5
Infections 18 (2.9) 10 (4.8) 1.7 0.8-3.7 1.1 0.5-2.6
CVD composite 36 (5.8) 23 (11.1) 2.0 1.2-3.5 1.7 0.9-3.1
  1. * Adjusted for the logistic EuroSCORE
  2. Adjusted for the logistic EuroSCORE and estimated glomerular filtration rate
  3. Adjusted for the logistic EuroSCORE, Charlson Comorbidity Index and type of surgery
  4. Short-term is defined as 30-day follow-up
  5. Long-term is defined as follow-up from day 31 until 365
  6. CI - Confidence interval; CVD - Cardiovascular disease; MI - Myocardial infarction; OR - Odds ratio; PCI - Percutaneous coronary intervention